Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou-Gehrigs Disease”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Study completedNCT00748501
What this trial is testing

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Sangamo Therapeutics 45
Large-scale testing (Phase 3)Study completedNCT01281189
What this trial is testing

Phase 3 Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 942
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06315608
What this trial is testing

MRG-001 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseMotor Neuron Disease+1 more
MedRegen LLC 10
Large-scale testing (Phase 3)Study completedNCT03548311
What this trial is testing

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Eisai Co., Ltd. 130
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Not applicableUnknownNCT00420719
What this trial is testing

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Synapse Biomedical 100
Testing effectiveness (Phase 2)Looking for participantsNCT06527222
What this trial is testing

Ranolazine in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Swathy Chandrashekhar, MBBS 72
Large-scale testing (Phase 3)Study completedNCT04436510
What this trial is testing

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 167
Not applicableStudy completedNCT00786032
What this trial is testing

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
US Department of Veterans Affairs 27
Not applicableStudy completedNCT00809224
What this trial is testing

Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
University of Michigan 92
Testing effectiveness (Phase 2)Study completedNCT00647296
What this trial is testing

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 194
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Large-scale testing (Phase 3)Study completedNCT00706147
What this trial is testing

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 38
Not applicableStudy completedNCT00677768
What this trial is testing

Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig's DiseasePrimary Lateral Sclerosis+2 more
Massachusetts General Hospital 475
Large-scale testing (Phase 3)Study completedNCT00444613
What this trial is testing

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Eisai Co., Ltd. 373
Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04220021
What this trial is testing

Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Who this might be right for
C9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia
University of Florida 41
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Large-scale testing (Phase 3)Study completedNCT05740813
What this trial is testing

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 310
Load More Results